Beshay N Zordoky

13PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Social epidemiologyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 12, 2026
Evaluation of Growth Differentiation Factor 15 as an Early Biomarker of Anthracycline-Induced Cardiotoxicity Using an Integrated PK/PD Model.

|Feb 27, 2026
Integrated Omics Approach to Delineate the Mechanisms of Doxorubicin-Induced Cardiotoxicity.

Mohamed S Dabour, Ibrahim Y Abdelgawad, Bushra Sadaf

|Dec 23, 2025
Substrain-Dependent Differences in Doxorubicin-Induced Cardiotoxicity in Adult C57BL/6 Mice.

Mary R Daniel, Marianne K O Grant, Mohamed S Dabour

|Dec 08, 2024
Canagliflozin differentially modulates carfilzomib-induced endoplasmic reticulum stress in multiple myeloma and endothelial cells.

Mohamed S Dabour, Mina Y George, Marianne K O Grant

|Jun 27, 2024
Empagliflozin Alleviates Carfilzomib-Induced Cardiotoxicity in Mice by Modulating Oxidative Stress, Inflammatory Response, Endoplasmic Reticulum Stress, and Autophagy.

Mina Y George, Mohamed S Dabour, Eman Rashad

|Jan 20, 2024
Sex-related differences in delayed doxorubicin-induced cardiac dysfunction in C57BL/6 mice.

Ibrahim Y Abdelgawad, Benu George, Marianne K O Grant

Pageof 3

Frequent Collaborators

7 joint publications

Marianne K O Grant

4 joint publications

Ibrahim Y Abdelgawad

4 joint publications

Mohamed S Dabour

2 joint publications

Kevin Agostinucci